Lv71
3530 积分 2022-11-21 加入
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
1个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
1个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
4个月前
已完结
异甘草酸镁对化疗药物致初治胃肠道肿瘤患者肝损害的预防作用
5个月前
已完结
Advances in Causes and Treatment of Autism
5个月前
已完结
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
8个月前
已关闭
Phase Ib study of anlotinib in combination with anti-PD-L1ab(TQB2450) in patients with advanced acral melanoma
1年前
已完结
What's the latest with investigational drugs for soft tissue sarcoma?
1年前
已完结
The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
1年前
已完结
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
1年前
已完结
皖公网安备34019202002308
